The majority of withdrawals have been due to commercial rationalisation decisions. Products highlighed in bold apply to the current month. Agenerase Benoral Benph Bipreterax Calcort Cardene Cefrom Dicynene Fansidar Femodene Flucandid Intal Kinidin Durules Largactil Liquivisc MXL Melleril Migranat Myocrisin Nuvelle Oestrogel Orudis Piportil Premdoc Psorimed Quinapro Rimactane Rimactizid Rynacrom Sectral Surgam SA Sustanon Tilade [...]